Sanofi Market Cap ($105.72 Billion)
Market Cap & Net Worth: Sanofi (SNW2)
Sanofi market cap. Sanofi (F:SNW2) has a market capitalization of $105.72 Billion (€90.43 Billion) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #238 globally and #45 in its home market, demonstrating a 8.20% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sanofi's stock price €39.60 by its total outstanding shares 2428995514 (2.43 Billion). Also see SNW2 cash flow metrics for how efficiently the company converts equity into cash flow.
Sanofi Market Cap History (2015–2026)
Sanofi market cap history from 2015 to 2026. Data shows growth from $76.03 Billion to $112.45 Billion (2.79% CAGR). Check latest Sanofi stock price today for real-time trading data and today's change.
Sanofi Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sanofi's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore SNW2 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.99x
Sanofi's market cap is 2.99 times its annual revenue
Latest Price to Earnings (P/E) Ratio
23.80x
Sanofi's market cap is 23.80 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $75.77 Billion | $34.71 Billion | $4.71 Billion | 2.18x | 16.09x |
| 2017 | $74.40 Billion | $36.20 Billion | $8.43 Billion | 2.05x | 8.82x |
| 2018 | $80.25 Billion | $35.68 Billion | $4.31 Billion | 2.25x | 18.64x |
| 2019 | $103.92 Billion | $37.63 Billion | $2.81 Billion | 2.76x | 37.04x |
| 2020 | $93.17 Billion | $37.37 Billion | $12.31 Billion | 2.49x | 7.57x |
| 2021 | $109.10 Billion | $39.17 Billion | $6.22 Billion | 2.78x | 17.53x |
| 2022 | $117.43 Billion | $45.39 Billion | $6.72 Billion | 2.59x | 17.48x |
| 2023 | $120.55 Billion | $41.62 Billion | $5.40 Billion | 2.90x | 22.32x |
| 2024 | $132.33 Billion | $44.29 Billion | $5.56 Billion | 2.99x | 23.80x |
Competitor Companies of SNW2 by Market Capitalization
Companies near Sanofi in the global market cap rankings as of November 3, 2026. Also see balance sheet size of Sanofi for a full breakdown of the balance sheet.
Key companies related to Sanofi by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #12 globally with a market cap of $1.06 Trillion USD.
- Eli Lilly and Company (SA:LILY34): Ranked #20 globally with a market cap of $853.51 Billion USD ( R$4.35 Trillion BRL).
- Johnson & Johnson (NYSE:JNJ): Ranked #29 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #42 globally with a market cap of $356.49 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #12 | Eli Lilly and Company | NYSE:LLY | $1.06 Trillion | $1410.99 |
| #20 | Eli Lilly and Company | SA:LILY34 | $853.51 Billion | R$153.70 |
| #29 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $270.56 |
| #42 | AbbVie Inc | NYSE:ABBV | $356.49 Billion | $288.84 |
Market Capitalization of Sanofi (2015–2026)
Market capitalization of Sanofi from 2015 to today. Between 2015 and today, Sanofi's market cap moved from $76.03 Billion to $ 112.45 Billion, with a yearly change of 2.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €112.45 Billion | -2.94% |
| 2025 | €115.86 Billion | -12.45% |
| 2024 | €132.33 Billion | +9.77% |
| 2023 | €120.55 Billion | +2.65% |
| 2022 | €117.43 Billion | +7.64% |
| 2021 | €109.10 Billion | +17.10% |
| 2020 | €93.17 Billion | -10.35% |
| 2019 | €103.92 Billion | +29.49% |
| 2018 | €80.25 Billion | +7.87% |
| 2017 | €74.40 Billion | -1.80% |
| 2016 | €75.77 Billion | -0.34% |
| 2015 | €76.03 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Sanofi was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $105.72 Billion USD |
| MoneyControl | $105.72 Billion USD |
| MarketWatch | $105.72 Billion USD |
| marketcap.company | $105.72 Billion USD |
| Reuters | $105.72 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sanofi
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting aga… Read more